A pill to talk about diabetic weight loss surgery in the UAE

A new type of non-invasive treatment, called "surgical pill", can improve the quality of life of many patients with type 2 diabetes in the UAE and the region as a whole.

The latest statistics in the United Arab Emirates indicate an obesity of 34.5% in 2016. The number of people with type 2 diabetes in 2017 is estimated at about 1 million (17.3% of the population aged 20 to 79 years ).

Despite the obvious benefits of weight loss surgery for diabetic patients and their benefits in terms of reducing the risk of cancer and increasing the patient's life expectancy, the number of patients who accept this surgery among patients eligible remains low, at 1-2% of them only.

Many diabetics do not meet current surgical standards and therefore continue to suffer from the disease, but researchers are currently developing a pill that the doctor can prescribe as an alternative to surgery.

A pill sings for weight loss surgery in diabetics

A team of researchers at Brigham & Wimans Hospital in Boston, Massachusetts, has developed a new compound called "Lucy" (the intestinal cavity) that produces a viscous powder that envelops the body. intestine and constitutes a barrier on the first part of the intestine similar to surgery. Infectious disease.

The Lucy compound can encapsulate healthy tissues, forming a temporary physical barrier against the intestinal cavity, either inside or on the surface, so that nutrients, including sugar, are not absorbed.

Dr. Ali Tavakoli, Head of the Department of General Surgery and Gastrointestinal Surgery and Co-Director of the Brigham & Williams Hospital Weight and Metabolism Surgery Center and Assistant Professor of Surgery at Harvard Medical School, said : "With the spread of diabetes in the Middle East, a safe and non-invasive treatment that is also effective for obesity surgery in weight loss and diabetes control, but without the associated risk."

"Through bioengineering, the Brigham & Wimans Hospital team has achieved similar results in diabetic patients who have undergone gastric bypass surgery to reduce diabetes by developing a new approach that can provide these beneficial results to a much larger group of patients. "

Dr. Hossam Trabelsi, specialist in obstetrics and obstetrics at Dubai's Medcare Hospital, said: "There is no doubt that the first to undergo surgery today are type 2 diabetic patients whose BMI exceeds 35. Plasma glucose, insulin and HbA1c concentrations in the normal range in 80 to 100% of obese patients who have undergone surgery.In general, three patients on five find a marked improvement in insulin levels within a week after surgery. "